{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:54:20Z","timestamp":1790942060678,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.mrgentox.2005.01.013","type":"journal-article","created":{"date-parts":[[2005,4,28]],"date-time":"2005-04-28T13:14:30Z","timestamp":1114694070000},"page":"105-119","source":"Crossref","is-referenced-by-count":7,"title":["The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration"],"prefix":"10.1016","volume":"583","author":[{"given":"V. Koneti","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turid","family":"Knutsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darawalee","family":"Wangsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Mike","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Langham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill J.","family":"Egorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Balis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Fojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2005.01.013_bib0005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V27.6.771.771","article-title":"Cytogenetic and morphologic abnormalities in human bone marrow cells during cytosine arabinoside therapy","volume":"2","author":"Bell","year":"1966","journal-title":"Blood"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0010","series-title":"Risk Factors and Multiple Cancer","first-page":"45","article-title":"Chromosomal damage by radiation and antitumor agents","author":"Whang-Peng","year":"1984"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1200\/JCO.1993.11.2.199","article-title":"Secondary acute myeloid leukemia following treatment with Epipodophyllotoxins (editorial, comment)","volume":"11","author":"Murphy","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0020","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.1997.15.4.1583","article-title":"Secondary acute myelogenous leukemia following safe exposure to etoposide","volume":"15","author":"Stine","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000282992","article-title":"Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumour","volume":"15","author":"Nonomura","year":"1997","journal-title":"Urol. Int."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/oxfordjournals.annonc.a010725","article-title":"Myelodysplasia and acute myeloid leukemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin","volume":"7","author":"Cremin","year":"1996","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.1998.16.3.1008","article-title":"Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant","volume":"16","author":"Laughlin","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0040","first-page":"163","article-title":"Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer","volume":"16","author":"Roman-Unfer","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004320050156","article-title":"Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard dose chemotherapy and high dose chemotherapy with stem cell support in patients with potentially curable malignancies","volume":"124","author":"Kollmannsberger","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<45::AID-AJH10>3.0.CO;2-1","article-title":"Prediction of therapy related acute myelogenous leukemia and myelodysplastic syndrome after autologous bone marrow transplant for lymphoma","volume":"56","author":"Legare","year":"1997","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1520-6823(1997)5:3<154::AID-ROI14>3.0.CO;2-6","article-title":"Leukaemogenesis, gene interplay, and the role of haematopoietic environment","volume":"5","author":"Lawler","year":"1997","journal-title":"Radiat. Oncol. Invest."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/tera.1420180107","article-title":"Teratogenic and cytogenetic effects of some plant derived antitumor agents","volume":"18","author":"Sieber","year":"1978","journal-title":"Teratology"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1471-0528.1968.tb02083.x","article-title":"Cytotoxic drugs in pregnancy","volume":"75","author":"Nicholson","year":"1968","journal-title":"J. Obstet. Gynecol. Br. Commonwealth"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0027-5107(96)00021-8","article-title":"Mutagenic damage to mammalian cells by therapeutic alkylating agents","volume":"355","author":"Sanderson","year":"1996","journal-title":"Mut. Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0075","first-page":"4393","article-title":"Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy","volume":"7","author":"Karnaoukhova","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0597-74","article-title":"Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm","volume":"16","author":"Robbins","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0085","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1172\/JCI119362","article-title":"Gene rearrangement: a novel mechanism for MDR-1 gene activation","volume":"99","author":"Mickley","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0090","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V91.5.1749","article-title":"Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines and human tumors","volume":"91","author":"Mickley","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1098-2264(199809)23:1<44::AID-GCC7>3.0.CO;2-6","article-title":"Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR-1\/P-glycoprotein, in drug selected cell lines and patients with drug refractory ALL","volume":"23","author":"Knutsen","year":"1998","journal-title":"Genes, Chrom. Cancer"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<110::AID-GCC14>3.0.CO;2-4","article-title":"Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone resistant cell lines","volume":"27","author":"Rao","year":"2000","journal-title":"Genes, Chrom. Cancer"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/mutage\/13.1.39","article-title":"Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP-16, using conventional Giemsa staining and chromosome painting techniques","volume":"13","author":"Mossesso","year":"1998","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0110","first-page":"3589","article-title":"Acquired DNA mutations associated with in vivo hydroxyurea exposure","volume":"11","author":"Hanft","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000134517","article-title":"Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts","volume":"76","author":"Cimini","year":"1997","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0120","unstructured":"Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals. ICH Harmonised tripartite guideline: Recommended for adoption to the regulatory bodies of the European Union, Japan and USA on 16 July 1997, (http:\/\/www.ich.org)."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0125","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.V93.6.1875.406k16_1875_1881","article-title":"The rhesus macaque as an animal model for hemophilia B gene therapy","volume":"93","author":"Lozier","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/095530096145049","article-title":"Stability of the translocation frequency following whole-body irradiation measured in rhesus monkeys","volume":"70","author":"Lucas","year":"1996","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0135","first-page":"253","article-title":"Human chromosome painting probes used to measure chromosome translocation in non-human primates: extrapolations from monkey to man","volume":"46","author":"Lucas","year":"1993","journal-title":"Radiat. Protect. Dosimetry"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0047-2484(82)80020-1","article-title":"Standardization of the karyotype of the Rhesus monkey, Macaca mulatta, and interspecific homologies with human chromosomes","volume":"11","author":"Soares MBA","year":"1982","journal-title":"J. Human Evol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1096-8644(199910)110:2<119::AID-AJPA1>3.0.CO;2-S","article-title":"Cytogenetic and fertility studies of a rheboon, rhesus macaque (Macaca mulatta) X baboon (Papio hamadryas) cross: further support for a single karyotype nomenclature","volume":"110","author":"Moore","year":"1999","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09553009414551321","article-title":"Metaphase yields from staphylococcal enterotoxin A stimulated peripheral blood lymphocytes of unirradiated and irradiated aged rhesus monkeys","volume":"66","author":"Hill","year":"1994","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0155","series-title":"The AGT Cytogenetics Laboratory Manual","first-page":"355","year":"1997"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0160","first-page":"736","article-title":"Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose dependent plasma clearance of thiotepa","volume":"49","author":"Heideman","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0165","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/jnci\/88.24.1840","article-title":"Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide","volume":"88","author":"Chen","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0170","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","article-title":"Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy","volume":"99","author":"Wilson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/07357909709047586","article-title":"Infusional chemotherapy for non-Hodgkin's lymphoma","volume":"15","author":"Molldrem","year":"1997","journal-title":"Cancer Invest."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0180","first-page":"2337","article-title":"High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support","volume":"3","author":"Morgan","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0185","first-page":"423","article-title":"Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion","volume":"13","author":"Mross","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00280-003-0579-y","article-title":"The schedule-dependent effects of etoposide in leukemic cell lines: a function of concentration and duration","volume":"51","author":"Liu","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1383-5718(03)00163-3","article-title":"Evaluation of cisplatin+5FU, carboplatin+5FU, and ifosfamide+epirubicin regimens using the micronuclei test and nuclear abnormalities in buccal mucosa","volume":"539","author":"Torres-Bugarin","year":"2003","journal-title":"Mut. Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0200","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.leu.2402130","article-title":"Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study","volume":"15","author":"Hunault-Berger","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0205","first-page":"6278","article-title":"Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers","volume":"47","author":"Kao-Shan","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0210","first-page":"3974","article-title":"Centrosome defects and genetic instability in malignant tumors","volume":"58","author":"Pihan","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02303580","article-title":"Microsatellite instability in breast cancer","volume":"4","author":"Rush","year":"1997","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000218026","article-title":"Microsatellite instability and loss of heterozygosity in primary breast tumors","volume":"18","author":"Sourvinos","year":"1997","journal-title":"Tumor Biol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0225","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1203668","article-title":"Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells","volume":"19","author":"Branch","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.bjc.6690360","article-title":"Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents","volume":"80","author":"Colella","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0235","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/35006670","article-title":"DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation","volume":"404","author":"Difilippantonio","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0240","first-page":"1727","article-title":"A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate","volume":"63","author":"Goldie","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0245","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng0497-406","article-title":"Hidden chromosome abnormalities in haematological malignancies detected by multicolor spectral karyotyping","volume":"15","author":"Veldman","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09553009214551821","article-title":"Rapid translocation frequency analysis in humans decades after exposure to ionizing radiation","volume":"62","author":"Lucas","year":"1992","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0255","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/mutage\/11.6.537","article-title":"A comparison of conventional metaphase analysis of Giemsa-stained chromosomes with multi-color fluorescence in situ hybridization analysis to detect chromosome aberrations induced by daunomycin","volume":"1","author":"Ellard","year":"1996","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0260","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1200\/JCO.1999.17.3.855","article-title":"Management of breast cancer during pregnancy using a standardized protocol","volume":"17","author":"Berry","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0265","unstructured":"PDQ Treatment Health Professionals: Breast Cancer and Pregnancy, <http:\/\/cancer.gov\/cancerinfo\/pdq\/treatment\/breast-cancer-and-pregnancy>."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0090-8258(90)90188-Q","article-title":"Combination chemotherapy and radiation for stage IV breast cancer during pregnancy","volume":"36","author":"Willemse","year":"1990","journal-title":"Gynec. Oncol."},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0275","first-page":"93","article-title":"Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukemia","volume":"10","author":"Giri","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0280","series-title":"Abstract #293 Presented at the 40th Annual Meeting of American Society of Hematology, Blood (Suppl. 1)","first-page":"72a","article-title":"Study of chemotherapy induced chromosomal aberrations in rhesus monkey bone marrows using Giemsa staining and spectral karyotyping","author":"Rao","year":"1998"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0285","series-title":"Categorical Data Analysis","author":"Agresti","year":"1990"},{"key":"10.1016\/j.mrgentox.2005.01.013_bib0290","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(04)17038-4","article-title":"Can the genotoxicity of chemotherapy be predicted?","volume":"364","author":"Pui","year":"2004","journal-title":"Lancet (Comment)"}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571805000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571805000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T04:06:36Z","timestamp":1586232396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571805000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1383571805000379"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2005.01.013","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}